RYTM - Rhythm Pharmaceuticals Inc (RYTM) Q1 2024 Earnings Call Transcript

2024-05-07 21:50:36 ET

Rhythm Pharmaceuticals, Inc (RYTM)

Q1 2024 Results Conference Call

May 07, 2024 8:00 AM ET

Company Participants

David Connolly - Executive Director, IR and Corporate Communications

David Meeker - Chairman, President, and CEO

Jennifer Lee - Executive Vice President, Head of North America

Yann Mazabraud - Executive Vice President, Head of International

Hunter Smith - Chief Financial Officer

Conference Call Participants

Derek Archila - Wells Fargo

Jeff Hung - Morgan Stanley

Dae Gon Ha - Stifel

Phil Nadeau - TD Cowen

Corinne Johnson - Goldman Sachs

Joseph Stringer - Needham & Company

Michael Higgins - Ladenburg Thalmann

Whitney Ijem - Canaccord Genuity

Presentation

Operator

Good day, and thank you for standing by. Welcome to Rhythm Pharmaceuticals Q1 2024 Earnings Conference Call. At this time, all participants are in a listen only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.

I would like now to turn the conference over to your first speaker today, David Connolly, Executive Director of Investor Relations and Corporate Communications. Please go ahead.

David Connolly

Thank you, Stephen. I'm Dave Connolly here at Rhythm Pharmaceuticals. For those of you participating on the conference call, our slides can be accessed and controlled by going to the Investors section on the Investors page of our website, ir.rhythmtx.com.

This morning, we issued a press release that provides our first quarter 2024 financial results and a business update, and that is available on our website. As listed on Slide 2 is our agenda. Here with me today in Boston are David Meeker, Chair, Chief Executive Officer and President; Jennifer Lee, Executive Vice President, Head of North America; Hunter Smith, our Chief Financial Officer; and Yann Mazabraud, Executive Vice President, Head of International is on the line joining us from Europe.

And on Slide 3, I'll remind you that this call contains remarks concerning future expectations, plans and prospects, which constitute forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in our most recent annual or quarterly reports on file with the SEC. In addition, any forward-looking statements represent our views as of only today and should not be relied upon as representing our views as of any subsequent dates. We specifically disclaim any obligation to update such statements....

For further details see: